Upstream Bio (UPB) Earnings Date & Reports

Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

UPB is expected to report earnings to rise 49.33% to -112 cents per share on November 05

Q3'26

Est.

$-1.12

Q1'26

Beat

by $0.10

Q4'25

Beat

by $0.06

The last earnings report on May 13 showed earnings per share of -75 cents, beating the estimate of -85 cents. With 277.87K shares outstanding, the current market capitalization sits at 313.29M.

View a ticker or compare two or three

UPB

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for UPB